본문 바로가기
KERD
논문KCI 등재

Recent developments in endoscopic ultrasound-guided radiofrequency ablation for pancreatic lesions

2

조회

0

다운로드

2

인용

0

참고문헌

키워드

초록

Radiofrequency ablation (RFA) has been regarded as an established technique to treat various diseases such as hepatocellular carcinoma, renal cell carcinoma and Barret’s esophagus. Although the application of RFA in the pancreas has been limited due to increased risk of adverse events, endoscopic ultrasound-guided RFA (EUS-RFA) has generated interest as a novel minimally invasive treatment modality which combines real-time visualization with a precise localization of the treatment procedure. For over a decade, the optimization of RFA devices have made EUS-RFA relatively safe, and several studies have supported its feasibility. However, there is insufficient evidence to suggest the appropriate indications and to describe long-term outcomes of EUS-RFA for various pancreatic neoplasms such as pancreatic neuroendocrine tumor, ductal adenocarcinoma, and cystic lesions. Therefore, this review focuses on the technical aspects and clinical applications of EUS-RFA for each pancreatic disease.

Abstract

Radiofrequency ablation (RFA) has been regarded as an established technique to treat various diseases such as hepatocellular carcinoma, renal cell carcinoma and Barret’s esophagus. Although the application of RFA in the pancreas has been limited due to increased risk of adverse events, endoscopic ultrasound-guided RFA (EUS-RFA) has generated interest as a novel minimally invasive treatment modality which combines real-time visualization with a precise localization of the treatment procedure. For over a decade, the optimization of RFA devices have made EUS-RFA relatively safe, and several studies have supported its feasibility. However, there is insufficient evidence to suggest the appropriate indications and to describe long-term outcomes of EUS-RFA for various pancreatic neoplasms such as pancreatic neuroendocrine tumor, ductal adenocarcinoma, and cystic lesions. Therefore, this review focuses on the technical aspects and clinical applications of EUS-RFA for each pancreatic disease.

참고문헌 (25)

  1. Vanella G, "Endosonography-guided radiofrequency ablation in pancreatic diseases : time to fill the gap between evidence and enthusiasm", J Clin Gastroenterol, 54, pp.591~601 (2020)
  2. Kim EJ, "NRF2 knockdown resensitizes 5-fluorouracil-resistant pancreatic cancer cells by suppressing HO-1 and ABCG2expression", Int J Mol Sci, 21, pp.4646~ (2020)
  3. Lee YN, "The safety of newly developed automatic temperature-controlled endobiliary radiofrequency ablation system for malignant biliary strictures : A prospective multicenter study", J Gastroenterol Hepatol, 34, pp.1454~1459 (2019)
  4. Kim EJ, "Intraductal temperaturecontrolled radiofrequency ablation in malignant hilar obstruction : a preliminary study in animals and initial human experience", Endosc Int Open, 7, pp.E1293~300 (2019)
  5. Kim EJ, "Endobiliary radiofrequency ablation for distal extrahepatic cholangiocarcinoma : a clinicopathological study", PLoS One, 13, pp.e0206694~ (2018)
  6. Cho JH, "Safety and effectiveness of endobiliary radiofrequency ablation according to the different power and target temperature in a swine model", J Gastroenterol Hepatol, 32, pp.521~526 (2017)
  7. Cho JH, "Long-term results of temperature-controlled endobiliary radiofrequency ablation in a normal swine model", Gastrointest Endosc, 87, pp.1147~1150 (2018)
  8. Barret M, "EUS-guided pancreatic radiofrequency ablation : preclinical comparison of two currently available devices in a pig model", Endosc Int Open, 7, pp.E138~43 (2019)
  9. Carrara S, "Endoscopic ultrasound-guided application of a new hybrid cryotherm probe in porcine pancreas : a preliminary study", Endoscopy, 40, pp.321~326 (2008)
  10. Petrone MC, "US-guided application of a new hybrid probe in human pancreatic adenocarcinoma : an ex vivo study", Gastrointest Endosc, 71, pp.1294~1297 (2010)
  11. Barthet M, "Endoscopic ultrasound-guided radiofrequency ablation for pancreatic neuroendocrine tumors and pancreatic cystic neoplasms : a prospective multicenter study", Endoscopy, 51, pp.836~842 (2019)
  12. Lee KJ, "Clinical outcomes of everolimus in patients with advanced, nonfunctioning pancreatic neuroendocrine tumors : a multicenter study in Korea", Cancer Chemother Pharmacol, 80, pp.799~805 (2017)
  13. Cho JH, "Prognostic validity of the American Joint Committee on Cancer and the European Neuroendocrine Tumors staging classifications for pancreatic neuroendocrine tumors : a retrospective nationwide multicenter study in South Korea", Pancreas, 45, pp.941~946 (2016)
  14. Choi JH, "Endoscopic ultrasoundguided radiofrequency ablation for management of benign solid pancreatic tumors", Endoscopy, 50, pp.1099~1104 (2018)
  15. Lakhtakia S, "EUS-guided radiofrequency ablation for management of pancreatic insulinoma by using a novel needle electrode(with videos)", Gastrointest Endosc, 83, pp.234~239 (2016)
  16. Oleinikov K, "Endoscopic ultrasound-guided radiofrequency ablation : a new therapeutic approach for pancreatic neuroendocrine tumors", J Clin Endocrinol Metab, 104, pp.2637~2647 (2019)
  17. Arcidiacono PG, "Feasibility and safety of EUS-guided cryothermal ablation in patients with locally advanced pancreatic cancer", Gastrointest Endosc, 76, pp.1142~1151 (2012)
  18. Crinò SF, "EUSguided radiofrequency ablation(EUS-RFA)of solid pancreatic neoplasm using an 18-gauge needle electrode : feasibility, safety, and technical success", J Gastrointestin Liver Dis, 27, pp.67~72 (2018)
  19. Scopelliti F, "Technique, safety, and feasibility of EUS-guided radiofrequency ablation in unresectable pancreatic cancer", Surg Endosc, 32, pp.4022~4028 (2018)
  20. Song TJ, "Initial experience of EUS-guided radiofrequency ablation of unresectable pancreatic cancer", Gastrointest Endosc, 83, pp.440~443 (2016)
  21. Wang D, "Mo1524 endoscopic ultrasound guided radiofrequency ablation for the treatment of advanced pancreatic carcinoma", Gastrointest Endosc, 77, pp.AB414~ (2013)
  22. Yang J, "Tu1357 feasibility and safety of EUS-guided radiofrequency ablation in unresectable pancreatic cancer", Gastrointest Endosc, 89, pp.AB588~589 (2019)
  23. Pai M, "Endoscopic ultrasound guided radiofrequency ablation, for pancreatic cystic neoplasms and neuroendocrine tumors", World J Gastrointest Surg, 7, pp.52~59 (2015)
  24. Giardino A, "Immunomodulation after radiofrequency ablation of locally advanced pancreatic cancer by monitoring the immune response in 10 patients", Pancreatology, 17, pp.962~966 (2017)
  25. Bang JY, "EUS-guided celiac ganglion radiofrequency ablation versus celiac plexus neurolysis for palliation of pain in pancreatic cancer : a randomized controlled trial(with videos)", Gastrointest Endosc, 89, pp.58~66.e3 (2019)

관련 논문AI추천

이 간행물의 다른 논문 (8건)